Lee Sujin, Houstis Nicholas E, Cunningham Thomas F, Brooks Liana C, Chen Kailin, Slocum Charles L, Ostrom Katrina, Birchenough Claire, Moore Elizabeth, Tattersfield Helena, Sigurslid Haakon, Guo Yugene, Landsteiner Isabela, Rouvina Jennifer N, Lewis Gregory D, Malhotra Rajeev
Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Vascular Surgery and Endovascular Therapy Division, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
JACC Heart Fail. 2025 Aug;13(8):102478. doi: 10.1016/j.jchf.2025.02.024. Epub 2025 Jun 10.
Iron is a critical factor in cardiac function, oxygen carrying capacity in the blood, and mitochondrial function in skeletal muscle, all of which are key elements of oxygen uptake and utilization during exercise. However, the impact of iron status on hemodynamic responses to exercise and component variables of peak oxygen consumption in patients with heart failure with preserved ejection fraction (HFpEF) is unknown.
The authors sought to determine the relationship between markers of iron status and comprehensive exercise response patterns and clinical outcomes in patients with HFpEF.
Cardiopulmonary exercise testing using cycle ergometry with invasive hemodynamic assessment was performed in 372 patients with HFpEF. Serum iron, transferrin saturation (Tsat), hepcidin, and ferritin were measured at the time of cardiopulmonary exercise testing, and additionally the Tsat/hepcidin ratio was used as a measure of iron homeostasis and hepcidin dysregulation, with low values reflecting inappropriate elevation in hepcidin level relative to iron bioavailability.
In this cohort, 66% had iron deficiency defined as ferritin <100 μg/L or ferritin 100-300 μg/L with Tsat <20%. Higher peak oxygen consumption was associated with higher Tsat% (ρ = 0.33; P < 0.0001), Tsat/hepcidin ratio (ρ = 0.23; P < 0.0001), and serum iron (ρ = 0.30; P < 0.0001) but was not associated with ferritin level. After adjustment for age, hypertension, diuretic use, hemoglobin level, and cardiac index at rest, the association between higher peak oxygen consumption with higher Tsat, Tsat/hepcidin, and iron remained significant (P ≤ 0.006 for all). Tsat, Tsat/hepcidin, and iron were also associated with lower pulmonary artery pressure/cardiac output slope and pulmonary capillary wedge pressure/cardiac output slope, whereas ferritin did not correlate with these exercise hemodynamic measures. Finally, Tsat independently predicted heart failure-free survival, with every higher tertile of Tsat corresponding to an HR of 0.60 (P = 0.002), whereas ferritin was not associated with outcomes.
In patients with HFpEF, Tsat%, but not ferritin levels, relates to more favorable overall metabolic and hemodynamic responses to exercise and better outcomes.
铁是心脏功能、血液携氧能力以及骨骼肌线粒体功能的关键因素,而这些都是运动过程中氧摄取和利用的关键要素。然而,铁状态对射血分数保留的心力衰竭(HFpEF)患者运动时血液动力学反应及峰值耗氧量组成变量的影响尚不清楚。
作者试图确定HFpEF患者铁状态标志物与综合运动反应模式及临床结局之间的关系。
对372例HFpEF患者进行了采用踏车测力计并进行有创血液动力学评估的心肺运动试验。在心肺运动试验时测定血清铁、转铁蛋白饱和度(Tsat)、铁调素和铁蛋白,此外,Tsat/铁调素比值用作铁稳态和铁调素失调的指标,其值较低反映相对于铁生物利用度而言铁调素水平不适当升高。
在该队列中,66%的患者存在缺铁,定义为铁蛋白<100μg/L或铁蛋白100 - 300μg/L且Tsat<20%。较高的峰值耗氧量与较高的Tsat%(ρ = 0.33;P<0.0001)、Tsat/铁调素比值(ρ = 0.23;P<0.0001)和血清铁(ρ = 0.30;P<0.0001)相关,但与铁蛋白水平无关。在对年龄、高血压、利尿剂使用、血红蛋白水平和静息心指数进行校正后,较高的峰值耗氧量与较高的Tsat、Tsat/铁调素和铁之间的关联仍然显著(所有P≤0.006)。Tsat、Tsat/铁调素和铁还与较低的肺动脉压/心输出量斜率以及肺毛细血管楔压/心输出量斜率相关,而铁蛋白与这些运动血液动力学指标无相关性。最后,Tsat独立预测无心力衰竭生存期,Tsat每升高一个三分位数,对应的风险比为0.60(P = 0.002),而铁蛋白与结局无关。
在HFpEF患者中,与运动的总体代谢和血液动力学反应更有利以及更好的结局相关的是Tsat%,而非铁蛋白水平。